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Abstract
Canine cutaneous mast cell tumors (ccMCTs) are currently graded according to Patnaik and Kiupel grading schemes. The qua-
litative and semiquantitative parameters applied in these schemes may lead to inter- and intraobserver variability. This study
investigates the prognostic value of volume-weighted mean nuclear volume ( vv ), a stereological estimation that provides infor-
mation about nuclear size and its variability. vv of 55 ccMCTs was estimated using the “point-sampled intercept” method and
compared with histological grade and clinical outcome. The clinical history of dogs treated with surgical excision alone
was available for 30 ccMCTs. Statistical differences in vv were found between grade II (x¼ 115 + 29 mm3) and grade III ccMCTs
(x¼ 197 + 63 mm3), as well as between low-grade (x¼ 113 + 28 mm3) and high-grade ccMCTs (x¼ 184 + 63 mm3). An optimal
cutoff value of vv  150 mm3 and vv  140 mm3 was determined for grade III and high-grade ccMCTs, respectively. In terms of
prognosis, vv was not able to predict the clinical outcome in 42% of the cases; however, cases with vv <125 mm
3 had a favorable
outcome. These results indicate that, despite having limited prognostic value when used as a solitary parameter, vv is highly
reproducible and is associated with histological grade as well as with benign behavior.
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Canine cutaneous mast cell tumors (ccMCTs) are among the
most frequently diagnosed skin tumors in dogs.24,41,43 These
tumors display a variable and unpredictable biological
behavior, ranging from benign behavior to potentially fatal
metastatic tumors.13,27 Tumor grade is widely used for prog-
nostication;4,13,25 however, no single parameter can accurately
predict the biological behavior of ccMCTs. Several additional
prognostic factors have been studied to improve ccMCT prog-
nostication, including cytological grade,6,29 expression pattern
of KIT protein,14 detection of c-KIT mutations,40,42 prolifera-
tion markers,41,43 and margin evaluation.29,30
Most histological grading schemes rely on the subjective
evaluation of morphologic and cytological parameters, which
are prone to personal bias and often lead to intra- and inter-
observer variability.1,28 In the case of ccMCTs, the most fre-
quently used grading systems are those of Patnaik and Kiupel.
The Patnaik system grades ccMCTs as grade I (G1), II (G2),
and III (G3) according to the degree of mast cell differentia-
tion, morphology, cellularity, extent of tissue involvement,
stromal reaction, and mitotic count.25 One of the problems
with this grading system is the pronounced interobserver
variability, particularly among the grading of G1 and G2
ccMCTs.13,22,23,27,38,40 To overcome the subjectivity associ-
ated with Patnaik grading, a 2-tier grading scheme was
developed by Kiupel et al.13 The latter grades ccMCTs as
low-grade (LG) or high-grade (HG) based on semiquantitative
parameters, such as number of mitotic figures, multinucleated
nuclei and bizarre nuclei per 10 hpf, and the presence of
karyomegaly.13 Several studies have shown the use of Kiupel
grading not only significantly decreases interobserver varia-
tion but also has a superior prognostic value.13,27,40,41
This study investigated the advantage of quantifying nuclear
size and its variability to overcome the subjectivity associated
with ccMCT histological grading. Previous measures of
nuclear size have been studied in ccMCT cytological and his-
tological samples.18,38,39 These studies found associations
between either ccMCT nuclear area or perimeter and Patnaik
grade. Interestingly, statistical differences were found between
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G1 and G3 ccMCTs, as well as between G2 and G3, but not
between G1 and G2. Two-dimensional morphometrical esti-
mates have the disadvantage that the position and orientation
of a section plane across a 3-dimensional object influence the
size, shape, and frequency of the 2-dimensional profile.5,19
Consequently, although there is a correlation between nuclear
area or perimeter and the real nuclear size, the true relation
between these parameters is uncertain, no matter how elegant
the statistical model33 (Fig. 1). Design-based stereological
methods, on the other hand, are based on statistical sampling
and geometrical principles to recover 3-dimensional informa-
tion from 2-dimensional sections. These methods eliminate
assumptions about the object’s shape and orientation, thus
allowing for precise and reproducible measures of numerous
parameters, including nuclear size.5,19,28 Stereological mea-
sures of nuclear size are best performed with the “point-
sampled intercept” (PSI) method, which provides a measure
of volume-weighted mean nuclear volume ( vvÞ.11 vv is
volume-weighted, meaning that nuclei are sampled in propor-
tion to their volume, thus larger nuclei have greater probability
of being sampled. This measure is therefore a reflection of
nuclear size and pleomorphism, increasing not only as nuclei
enlarge but also with nuclear size variability.9,33 The PSI
method has been used not only in malignancy grading of solid
tumors,12,15–17,21,28,34,35,37 but also in mean particle volume
estimation of normal histological structures, such as pancreatic
islets and alveoli.2,3,32 This study estimates vv in ccMCTs and
compares it with histological grade and clinical outcome.
Materials and Methods
Case Selection and Histopathology
Fifty-five paraffin-embedded ccMCTs diagnosed in 2017 were
selected for this study from the archives of DNATech, Lis-
bon, Portugal. These cases were selected if the diagnosis
had been made at least 1 year before the start of the study
(May 2019). Three-micrometer sections were routinely pro-
cessed and stained with hematoxylin and eosin for tumor
grading and stereological estimates. Each tumor was blindly
graded according to the Patnaik and Kiupel grading schemes
by 3 experienced pathologists (IBV—ECVP board certified,
and SB and PF—professors of veterinary pathology with
more than 20 years experience). The final diagnosis was
established by the consensus of at least 2 observers. Histo-
logical grade was assigned according to the criteria
described in the original papers.14,25
Outcomes
Follow-up of dogs treated with surgical excision alone was
available for 30 cases. The veterinary clinicians provided clin-
ical data regarding existence of postsurgical local recurrence,
metastasis, and/or mast cell tumor-related death (including
euthanasia).
The minimum follow-up period was 1 year. Dogs with post-
surgical resolution of disease were given an outcome value of 0
(OC0), whereas outcome value of 1 (OC1) included cases that
died or were euthanized as a result of local recurrence or devel-
opment of nodal or visceral metastasis. The lateral and deep
surgical margins (cm) were also evaluated at the time of sub-
mission and compared between groups.
Stereology
vv was estimated in one section per tumor, produced by
sectioning the tumor perpendicularly to the epidermis.10,36
Measurements were made on the same slide previously used
for diagnostic evaluation and tumor grading9.
Whole-slide images were obtained (NanoZoomer-SQ Digi-
tal slide scanner, Hamamatsu Photonics) with 40 resolution
and 800 magnification. Measurements were performed on
newCAST stereological software (Visiopharm). In each slide,
the region of interest (ROI), that is, the total area of the tumor,
was delineated manually at low magnification. Within each
ROI, fields of view (1000, A ¼ 10300.84 mm2) were auto-
matically selected in a systematic random fashion by the soft-
ware. According to Gundersen and Jensen,11 approximately 75
nuclei per tumor are needed to accurately estimate vv , ranging
from 50 to 100 nuclei. The number of fields of view required
was influenced by the tumor’s cellularity. Fields of poor focus
with indistinguishable nuclear borders were excluded from
measurement.
vv of ccMCTs was estimated according to the PSI method, in
which the nuclei are sampled with probes of test-lines and
associated points, superimposed onto the fields of view.11
Figure 1. Two-dimensional representations of sections across
3-dimensional mast cells. The orientation of the slice influences not only
the frequency with which nuclei are sampled, but also their dimension.
Although there is a relation between the nuclear profile area and its
true size, this relation is uncertain due to the loss of 3-dimensional
information. The right and left panels represent 2 different sections
through that same cell population. The top panels are 3-dimensional
representations of the cells showing the location of slices. The lower
panels are the appearances of the resulting 2-dimensional sections.
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Every time a nucleus is hit by a point (þ), the associated test-line
creates an intercept across the nuclear profile, whose length (l30)
is measured by marking the nuclear borders (see Fig. 2). These
lines were randomly rotated between fields, allowing randomiz-
ing of the nuclei and orientation in which these were measured.11
In total, 4 measurements were performed per tumor (MC—3
measurements, PF—1 measurement).







In which l30 is the cubed intercept length (mm
3) and n is the
number of intercepts measured.
Statistical Analysis
Statistical analysis was performed using R software with the
DescTools (version 0.99.37),31 irr (version 0.81.4),8 ggplot2
(version 3.2.1),44 and pROC packages (version 1.14.0).26
For quantitative variables, such as vv measurements, before
any hypothesis testing, normality was assessed with Shapiro-
Wilk test and homoscedasticity with Levene test; following the
obtained results, a parametric or nonparametric approach was
selected. For qualitative variables, w2 test or Fisher exact test
were used, depending on the number of cases for each category.
Regarding Patnaik and Kiupel grading, the agreement
among pathologists was evaluated with Fleiss’ k statistics.20
Considering the paired measurements (different measures
from the same sample), the differences between vv measure-
ments (including the average) and the concordance with
average were assessed with nonparametric Friedman’s test and
the Lin’s concordance correlation coefficient, respectively. To
evaluate differences of vv between Patnaik and Kiupel grades, a
parametric Welch 2-sample t-test was used. The ability of vv to
discriminate histological grades was assessed using receiver
operating characteristics (ROC) curve. The association
between tumor grade and mortality was investigated by means
of Kaplan-Meier curves.
For the variable Outcome, a subset of 30 cases for which we
had information on the variables age, sex, breed, and surgical
margins was used. To assess if there were any differences
between outcome on those variables, as well as differences of
vv between outcomes, a nonparametric Wilcoxon’s sum-rank
test was used.
To determine if the vv measurements could be used to effi-
ciently discriminate between outcomes, a 2-step analysis was
performed: Using an ROC curve, the ability of vv to correctly
identify the outcome was assessed. Next, considering the
impact that confounding variables can influence the measure-
ments, a multivariate logistic regression was performed using
age and sex in addition to vv . To assess the quality of the overall
capability of regressions to explain our data, we used McFad-
den’s pseudo-R2. Additionally, using the cutoff calculated in
the ROC curve analysis to stratify the population, survival
analysis was performed by means of Kaplan-Meier curves, and
the log rank test for comparison of the survival among groups.
For all analyses, a value of P < .05 was considered as statisti-
cally significant.
Results
Fifty-five ccMCTs were graded by consensus among 3 pathol-
ogists based on Patnaik and Kiupel grading systems. Based on
the Patnaik grading system, 39 (71%) ccMCTs were G2 and 16
(29%) as G3. No tumors were diagnosed by consensus as G1,
even though 11 tumors were diagnosed as G1 by 1 out of 3
pathologists. The agreement among pathologists was fair in
Patnaik grading (k ¼ 0.32), with 44% concordance in the
assignment of G2 and 56% concordance in the assignment of
G3 (Table 1). G3 ccMCTs were associated with increased
Figure 2. Estimation of mean nuclear volume using the point-sampled
intercept method. Fields of view from a mast cell tumor are automati-
cally generated with a constant step size. The nuclear profiles are
sampled with points (blue hash marks) and the associated test-lines cre-
ate linear intercepts across these profiles. The length of the intercepts is
traced by marking the nuclear borders in the direction of the line (green
hash marks). The goal is to measure *75 intercepts per tumor.
Table 1. Grade Assignment for 55 Canine Cutaneous Mast Cell
Tumors by 3 Pathologistsa. The Data Show the Number and
Percentage of Cases.
Patnaik n Agreement Disagreement
Grade 2 39 17 (44%) 22 (56%)
Grade 3 16 9 (56%) 7 (44%)
All grades 55 26 (47%) 29 (53%)
Kiupel n Agreement Disagreement
Low-grade 35 23 (66%) 12 (34%)
High-grade 20 11 (55%) 9 (45%)
All grades 55 34 (62%) 21 (38%)
aThe data show the number and percentage of cases.
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mortality and shorter survival time (Fig. 3). Based on the
Kiupel grading system, 35 (64%) ccMCTs were diagnosed
as LG and 20 (36%) as HG. There was moderate agreement
in Kiupel grading (k ¼ 0.46), with 66% concordance in the
assignment of LG and 55% concordance in the assignment of
HG ccMCTs (Table 1). Overall, LG were graded as G2 and
HG were graded as G3, except for 4 HG graded as G2. HG
ccMCTs were associated with increased mortality and shorter
survival time (Fig. 4).
Each tumor was measured by 2 observers, totaling 4 mea-
surements per tumor, and each measurement took approxi-
mately 10 minutes. To ease the following analysis, the
average of those 4 measurements was calculated and compared
with the obtained data. There were no statistical differences
among measurements including the average (see Fig. 5) with
this yielding concordance coefficients very close to 1 for the 4
original measurements (Fig. 6). Therefore, the average of the
measurements was used as a proxy of the vv values.
vv was estimated in a total of 55 ccMCTs and ranged from
38.6 to 363.3 mm3. vv increased significantly with histological
grade and statistical differences were found between G2 and
G3 ccMCTs (P < .001; Fig. 7, Table 2), as well as between LG
and HG ccMCTs (P < .001; Fig. 8, Table 2). The discriminative
power of vv between grades was fairly accurate in Patnaik
grading (AUC ¼ 91.4%; 95% confidence interval [CI]
82.1% to 100%), while it was less precise in Kiupel grading
(AUC ¼ 87.7%; 95% CI 77.3% to 98.1%). In Patnaik grading,
a vv greater than or equal to 150.3 mm
3 classified ccMCT as
G3 with 89.7% specificity and 87.5% sensitivity (Fig. 9). In
Kiupel grading, a vv greater than or equal to 140.3 mm
3 clas-
sified a ccMCT as HG with 88.6% specificity and 80.0%
sensitivity (Fig. 10).
To access the differences in vv between clinical outcomes,
30 cases were selected from our dataset based on the condition
that (1) these dogs were treated with surgery alone and (2)
follow-up data as well as age, sex, breed, and surgical margins
were available. Of these, 17 were females (57%) and 13 were
males (43%), including 8 mixed-breed dogs, 6 Labrador Retrie-
vers, 3 Golden Retrievers, 3 French Bulldogs, 2 Boxers, 2
Beagles, 1 Pug, 1 Weimaraner, 1 Basset Hound, 1 Yorkshire
Terrier, 1 Bouvier Bernois, and 1 English Bulldog. The mean
age at surgical excision was 8 + 2.9 years, and the follow-up
period ranged from 12 to 27 months. During this period, 5 dogs
developed an additional ccMCT at the original tumor location
and 3 dogs developed ccMCTs at different locations (consid-
ered de novo). The OC0 group included 24 dogs that were alive
at the end of this study. Of these, 23 had no signs of local or
distant recurrence, and one had local recurrence. The OC1
group included 6 dogs that died due to ccMCT-related disease,
5 of which were euthanized. These dogs included 1 case of
local recurrence, 1 case of lymph node metastasis, 1 case of
Figures 3–4. Survival curves for mortality in 30 canine mast cell tumors, graded according to the Patnaik grading system (Fig. 3) and the Kiupel
system (Fig. 4). Abbreviations: G2, Patnaik grade 2; G3, Patnaik grade 3; LG, Kiupel low-grade; HG, Kiupel high-grade.
Figures 5–6. Figure 5. Comparison between the values of each
individual measurement (y-axis) and the average of the 4 measure-
ments (x-axis). Each different shape is one measurement. Figure 6.
Lin’s concordance correlation coefficient between measurements.
4 Veterinary Pathology XX(X)
distant visceral metastasis, and 3 cases of both local recurrence
and distant metastasis. When cytology and histology were not
performed, the occurrence of presumptive local recurrence and
distant metastasis was based on regrowth of a mass or visceral
sonographic alterations.
There were no differences between OC0 and OC1 vv accord-
ing to age, sex, and surgical margins (P > .05. Supplemental
Table S1). Breed could not be statistically analyzed because
there were too many categories.
The 24 OC0 cases included 22 G2/LG ccMCTs and
2 G3/HG ccMCTs. The 6 OC1 cases included 1 LG and
5 HG, or 3 G2 and 3 G3. vv ranged from 87.1 to 214.2 mm
3,
and was statistically different between OC0 and OC1
(P ¼ .025; Fig. 11, Table 3). Although vv values overlapped
between groups, the 2 cases with highest vv of OC0 coin-
cided with the ones graded as G3/HG. Similarly, cases with
the lowest vv in OC1 group were graded as G2, in spite of a
poor outcome (Supplemental Table S1).
The potential of vv to differentiate the clinical outcomes of
these tumors was moderate (AUC ¼ 79.9%; 95% CI 62.5% to
97.2%). A vv greater than or equal to 124.8 mm
3 identified a
ccMCT with poor prognosis (OC1 cases) with 100% sensitivity
but only 58.3% specificity (Fig. 12).
By using the cutoff value of 124.8 mm3 to separate cases and
assessing their mortality, statistically significant differences
were observed between cases, with 100% of the animals with
vv below 124.8 mm
3 alive at the end of the study (Fig. 13). Even
though vv showed potential to identify benign behavior, the
multivariate logistic regression analysis determined that, when
age, sex, and margins are considered, vv did not show signifi-
cant capability to predict the outcome, despite the model hav-
ing McFadden’s pseudo-R2 of 0.39.
Discussion
Our results identified significant variability among pathologists
in ccMCT grading. As expected, there was greater consistency
in Kiupel grading,13,27,40,41 and greater inconsistency in Pat-
naik grading particularly in the assignment of G2. These results
are in accordance with previous studies; however, the concor-
dance between pathologists was lower in this study.13,27,40
Although G1 was assigned to 11 tumors by 1 of 3 pathologists,
no ccMCTs were graded G1 by consensus in this study. How-
ever, G1 ccMCTs are composed of monomorphic, well-
differentiated mast cells, hence these tumors would, in theory,
have lower vv values than G2 ccMCTs. Previous morphometric
studies did not find significant differences between G1 and G2
ccMCTs nuclear perimeter and nuclear area.18,38,39 Regardless,
G1 ccMCTs should be included in future larger studies of vv .
The PSI method allowed the measurement of vv of 55
ccMCTs with high intra- and interobserver reproducibility,
taking approximately 10 minutes per tumor. vv was associated
with Patnaik and Kiupel grade, with cutoff values of 150 and
140 mm3 for G3 and HG, respectively. The slightly lower spe-
cificity and sensitivity of vv values for Kiupel grade could be
related to grading of HG ccMCTs, since these only need to
fulfill one of the criteria proposed by Kiupel et al14; thus,
Figures 7–8. Comparison of the mean nuclear volume values among Patnaik and Kiupel histological grades from 55 cases of canine mast cell
tumors. The boxes show first quartile, second quartile (median), and third quartile. The whiskers represent the range (minimum and maximum)
values. Mean nuclear volumes are significantly different between grade 2 and grade 3 (Fig. 7), and between low-grade and high-grade (Fig. 8) mast
cell tumors (Welch 2-sample t test).
Table 2. Mean Nuclear Volumes (mm3) Among Histological Grades
of 55 Cutaneous Mast Cell Tumors.
Grade n Mean SD Range P Value
Grade 2 39 115.1 28.8 38.6–175.7 .001
Grade 3 16 196.8 65.5 102.1–363.3
Low-grade 35 112.7 27.9 38.6–175.7
High-grade 20 184.7 63.0 99.5–363.1 .001
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karyomegaly and nuclear pleomorphism are less determinant.
For instance, a tumor with 8 mitosis per 10/hpf would be clas-
sified as a HG ccMCT, independently of the nuclear size and/or
variability.
Previous morphometric studies also found an association
between Patnaik grade and both nuclear area and peri-
meter.18,38,39 In comparison with nuclear morphometry, vv has
the advantage of being “design-based,” meaning that nuclei are
sampled with points and lines, independently of nuclear shape
and orientation. Additionally, the PSI method provides a
volume-weighted measurement of nuclear volume, meaning
that nuclear size is favored. Therefore, larger nuclei have
greater probability of being sampled.11 Particularly in poorly
differentiated ccMCTs, the presence of lobulation and indenta-
tion is frequent, thus the elimination of assumptions about
nuclear shape and orientation is required to perform statisti-
cally sound and reproducible estimations.
In terms of clinical outcome, vv values were predictive of
benign behavior, with 100% survival of dogs with ccMCT vv
<125 mm3. However, a vv above 125 mm
3 was associated with
postsurgical progression of disease with 58% sensitivity and
100% specificity. Even though vv was able to identify a good
outcome, when a multivariate analysis was performed, the vari-
able vv was no longer statistically significant. Kiupel grading
Figures 9–10. Receiver operating characteristics curves for mean nuclear volume values according to Patnaik (Fig. 9) and Kiupel (Fig. 10)
grading systems from 55 cases. For the Patnaik system (Fig. 9), a mean nuclear value150.3 mm3 identifies a grade 3 mast cell tumor with 89.7%
specificity and 87.5% sensitivity. For the Kiupel system (Fig.10), a mean nuclear value 140.3 mm3 identifies a high-grade mast cell tumor with
88.6% specificity and 80.0% sensitivity. Abbreviations: G2, Patnaik grade 2; G3, Patnaik grade 3; LG, Kiupel low-grade; HG, Kiupel high-grade.
Figure 11. Comparison of the mean nuclear volume values among
clinical outcomes from 30 cases of canine mast cell tumor. The boxes
show the first quartile, second quartile (median), and third quartile.
The whiskers represent the range (minimum and maximum) values.
There is a significant difference between outcome OC0 (alive) and
OC1 (died) (Wilcoxon’s sum-rank test).
Table 3. Mean Nuclear Volumes (mm3) Among Clinical Outcomes
of 30 ccMCTs.
Outcome n Q1 Median Q3 Range P Value
OC0 24 99.5 111.8 133.5 87.1–214.1
OC1 6 131.8 157.4 171.1 125.5–186.0 .025
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was the strongest predictor of clinical outcome, agreeing with
previous evidence indicating its superior prognostic
value.13,27,40,41 Interestingly, OC0 included 2 HG/G3 ccMCTs
that corresponded to those with the highest vv values. Simi-
larly, OC1 included 1 G2/LG and 2 G2/HG ccMCTs with the
lowest vv values. The high association between histologic
grade and vv suggests that in order to identify outliers, addi-
tional prognostic factors which assess parameters other than
nuclear pleomorphism are required. However, considering the
small number of cases with poor outcome, a larger study is
needed to refine this cutoff.
Nevertheless, some ccMCTs are diagnosed as HG based on
the presence of karyomegaly, regardless of a low mitotic count.
Kiupel et al define karyomegaly as “nuclear diameters of at
least 10% of neoplastic mast cells vary by at least 2-fold”13 and
this is likely poorly reproducible. In fact, scoring of nuclear
pleomorphism has poor agreement between pathologists for
other tumors.7,28 Considering that vv was associated with high
reproducibility, it could be added to Kiupel grading system for
improving reproducibility in the assessment of nuclear
pleomorphism.
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